Sitagliptin Tied to Improved Outcomes among Diabetics with COVID-19

October 01, 2020

EASD 2020

European Association for the Study of Diabetes 2020 Annual Meeting

Increased Number of Menopause Symptoms Tied to Increased Cardiovascular Disease Risk

September 29, 2020

An analysis of data from the Women's Health Initiative is offering clinicians a look into the impact of menopause symptoms on cardiovascular health in older women.

David Cherney, MD: SGLT2 Inhibitors and Prescribing Responsibility

September 28, 2020

An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.

Study Finds Increased Exercise Lowers Mortality Risk 25-32% Among Diabetics

September 25, 2020

A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.

Metformin Could Slow Cognitive Decline, Reduce Dementia Incidence in Diabetics

September 24, 2020

Analysis of information from more than 1000 patients in Australia sheds light on the potential association between metformin use and slower cognitive decline in older individuals.

COVID-19 Lockdown May Have Improved Glycemic Control for Some Diabetics

September 23, 2020

Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.

Study Estimates Average Life Years Lost from Type 1, Type 2 Diabetes

September 23, 2020

Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.